获取演示
Now livetag icon
Ad Intelligence Presents: Ads in ChatGPT & Google. Download the reportbanner icon
Guardant Health

四月 2026

四月 2026的Guardant Health市场份额分析

Guardant Health is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
成立年份2012
员工1001 - 5000
年营收$500M - $1B
guardanthealth.com
Guardant Health
Guardant Health(包含公司地区分支机构)
  • guardanthealth.com
    guardanthealth.com
查看更多网站流量和参与度信息

Guardant Health收入截至 四月 2026为 500M - 1B

Guardant Health主要域名产生的收入

3 年中Guardant Health主要域名的收入

Guardant Health主要域名的收入

guardanthealth.comguardanthealth.com500M - 1B
使用销售情报查看更多信息

四月 2026的Guardant Health股票价格

Guardant Health的股票交易代码为 GH。您可以在下面查看过去 12 个月的Guardant Health股票表现(最多 四月 2026)


Guardant Health热门域名的总访问量

了解Guardant Health市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Guardant Health热门域名的平均访问时长

分析Guardant Health参与度指标。

过去 3 个月的平均访问时长

子公司明细
guardanthealth.comguardanthealth.com00:01:47
使用销售情报查看更多信息

Guardant Health热门域名的平均页面浏览量

了解Guardant Health如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Guardant Health 采用的主要技术

这些是排名前 Guardant Health 的顶级域名所使用的网站技术(按行业分列)

付费广告 (13)

DoubleClick

DoubleClick

营销 (6)

Google Marketing Platform

Google Marketing Platform

社交 (6)

Instagram

Instagram

小部件 (5)

更多技术

10

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Guardant Health 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Guardant Health is developing companion diagnostics for oncology on Apr 30th '26.NEW YORK - Guardant Health announced on Thursday that it has entered into a multi-year strategic collaboration with biopharma company Nuvalent to develop and potentially commercialize companion diagnostics for oncology.
新闻Guardant Health is developing companion diagnostics and support potential commercialization of targeted cancer therapies using the.Guardant Health announces multi-year strategic collaboration with Nuvalent to develop companion diagnostics and support potential commercialization of targeted cancer therapies using the Guardant Infinity(TM) platform.
新闻Guardant Health partnered with Nuvalent, Inc. on Apr 30th '26.PALO ALTO, Calif.-(BUSINESS WIRE)- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year strategic collaboration with Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, to support the development and potential commercialization of Nuvalent's oncology pipeline using the tissue and liquid offerings of the Guardant Infinity(TM) platform.

查看 Guardant Health 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。